Status:
COMPLETED
Anti Propionibacterium(P.) Acnes Activity of Epiduo® Gel Compared to Benzoyl Peroxide (BPO) 2.5% Gel
Lead Sponsor:
Galderma R&D
Conditions:
Acne Vulgaris
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
The purpose of this study is to evaluate the antibacterial activity of Epiduo® Gel (Adapalene 0.1% / Benzoyl Peroxide 2.5% Gel) on P. acnes compared to that of Benzoyl Peroxide 2.5% Gel.
Eligibility Criteria
Inclusion
- Subjects with facial acne,
- Subjects with high levels of P. acnes counts on the forehead
Exclusion
- Female Subjects who are pregnant, nursing or planning a pregnancy during the study,
- Subjects with acne conglobata, acne fulminans, secondary acne
- Subjects with known or suspected allergy to one of the test product
Key Trial Info
Start Date :
March 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2010
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT01188538
Start Date
March 1 2010
End Date
August 1 2010
Last Update
February 18 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dermatologiczna Klinika Uzdrowiskowa
Iwonicz-Zdrój, Poland, 38-440